MedPath

Effect of rTMS on HSP

Phase 3
Conditions
Hereditary spastic paraplegia.
Hereditary spastic paraplegia
G11.4
Registration Number
IRCT20170703034879N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Diagnosis based on Fink's Criteria
Signed written informed consent

Exclusion Criteria

History of Seizure
Uncontrolled hypertension
Cochlear implant
Cardiac Pacemaker
Foreign body in patient's body

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of lower limb spasticity based on modified Ashworth scale. Timepoint: Before intervention, upon completion of 5 sessions of rTMS, 1 moth after intervention. Method of measurement: Modified Ashworth Scale (MAS).
Secondary Outcome Measures
NameTimeMethod
Change in patients' mobility based on 10-meter walking test. Timepoint: Before intervention, upon completion of 5 sessions of rTMS, 1 month after intervention. Method of measurement: 10-meter Walking test.;Change in motor function of lower limb. Timepoint: Before intervention, upon completion of 5 sessions of rTMS, 1 month after intervention. Method of measurement: Fugl-Meyer Assessment of lower limb (FMA-LE).;Quality of Life. Timepoint: Before intervention, upon completion of 5 sessions of rTMS, 1 month after intervention. Method of measurement: Short form survey 36 (SF-36).
© Copyright 2025. All Rights Reserved by MedPath